Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma
Qisha Liu, Fan Li, Yaoyao Zhuang, et al.
Gut Pathogens (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

Interaction of the microbiota with the human body in health and diseases
Safaa Altveş, Hatice Kübra Yıldız, Hasibe Cıngıllı Vural
Bioscience of Microbiota Food and Health (2019) Vol. 39, Iss. 2, pp. 23-32
Open Access | Times Cited: 356
Gut microbiome in HCC – Mechanisms, diagnosis and therapy
Robert F. Schwabe, Tim F. Greten
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 230-238
Open Access | Times Cited: 275
Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome
Ziying Zhang, Haosheng Tang, Peng Chen, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 209
The Mechanisms of HBV-Induced Hepatocellular Carcinoma
Yu Jiang, Qiuju Han, Huajun Zhao, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 435-450
Open Access | Times Cited: 168
Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy
Connor Campbell, Mrunmayee Kandalgaonkar, Rachel M. Golonka, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 294-294
Open Access | Times Cited: 116
Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma
Pei‐Chang Lee, Chi-Jung Wu, Ya‐Wen Hung, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 6, pp. e004779-e004779
Open Access | Times Cited: 108
Hepatocellular Carcinoma in 2021: An Exhaustive Update
Cyriac Abby Philips, S Rajesh, Dinu Chandran Nair, et al.
Cureus (2021)
Open Access | Times Cited: 104
Large-scale microbiome data integration enables robust biomarker identification
Liwen Xiao, Fengyi Zhang, Fangqing Zhao
Nature Computational Science (2022) Vol. 2, Iss. 5, pp. 307-316
Open Access | Times Cited: 71
Evaluation of antibiotic resistance dissemination by wastewater treatment plant effluents with different catchment areas in Germany
Johannes Alexander, Norman Hembach, Thomas Schwartz
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 124
Role of Gut Microbiota in Hepatocarcinogenesis
Haripriya Gupta, Gi Soo Youn, Min Jea Shin, et al.
Microorganisms (2019) Vol. 7, Iss. 5, pp. 121-121
Open Access | Times Cited: 108
Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
Ruipeng Zheng, Guoqiang Wang, Zhiqiang Pang, et al.
Cancer Medicine (2020) Vol. 9, Iss. 12, pp. 4232-4250
Open Access | Times Cited: 93
Profiling of tumour-associated microbiota in human hepatocellular carcinoma
Seiga Komiyama, Takahiro Yamada, Nobuyuki Takemura, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 73
Hepatic stellate cell activation and senescence induced by intrahepatic microbiota disturbances drive progression of liver cirrhosis toward hepatocellular carcinoma
Boyuan Liu, Zewei Zhou, Yu Jin, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003069-e003069
Open Access | Times Cited: 65
Gut microbiome in gastrointestinal cancer: a friend or foe?
Yang Liu, Yoshifumi Baba, Takatsugu Ishimoto, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 10, pp. 4101-4117
Open Access | Times Cited: 51
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response
Yue Shen, Shengdi Wu, Yao Chen, et al.
Gut Microbes (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 47
A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma
Jinhuan Yang, Qikuan He, Fei Lü, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Bifidobacterium longum promotes postoperative liver function recovery in patients with hepatocellular carcinoma
Jingjing Yu, Peng Zhu, Linlin Shi, et al.
Cell Host & Microbe (2023) Vol. 32, Iss. 1, pp. 131-144.e6
Open Access | Times Cited: 29
The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
Georgia Saxami, Evangelia N. Kerezoudi, Christos Eliopoulos, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2023-2023
Open Access | Times Cited: 27
Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma
Weizheng Zhang, Xiaosong Xu, Liping Cai, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Distinct alterations of gut microbiota between viral- and non-viral-related hepatocellular carcinoma
Thananya Jinato, Songtham Anuntakarun, Nantawat Satthawiwat, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 13
Host-Gut Microbiota Metabolic Interactions and Their Role in Precision Diagnosis and Treatment of Gastrointestinal Cancers
Chunhao Cao, Siran Yue, Aiping Lu, et al.
Pharmacological Research (2024) Vol. 207, pp. 107321-107321
Open Access | Times Cited: 13
The role of microbiomes in gastrointestinal cancers: new insights
Aref Yarahmadi, Hamed Afkhami
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 12
An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome
Shuaiming Jiang, Wenyao Ma, Chenchen Ma, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
The role of gut microbiota in the occurrence and progression of non-alcoholic fatty liver disease
Huanzhuo Mai, Xing Yang, Yulan Xie, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 9
The Malignant Transformation of Viral Hepatitis to Hepatocellular Carcinoma: Mechanisms and Interventions
Huimin Yuan, Ruochen Xu, Senlin Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top